← All stocks

Protalix BioTherapeutics, Inc.

PLX Net buying

CIK 0001006281 #3972 in the set updated 19 Sep 2026

Bought (12 mo)

$101.36K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$314.16

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$314.16

1 of 1 sales

Net

+$101.05K

+$101.05K against sales at will

By person

10 insiders · 2 transactions

11.4×

Dror Bashan holds 11.4 times base salary in stock. $4.58M of shares against $401.84K in salary for 2025.

Salary from the company's own proxy. The shares are what Dror Bashan last reported holding, valued at $1.81, the price Common Stock was last bought or sold at on the open market here, on 19 Dec 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bashan Dror

PRESIDENT AND CEO

$101.36K (1)

—

+$101.36K

2,532,934

3.14%

$4.58M

+11.0%

Bar-Shalev Amos

Director

—

$314.16 (1)

−$314.16

7,500

0.0093%

$13.58K

+4,364%

Rubin Eyal

Sr. VP and CFO

—

669,010

0.8303%

$1.21M

+17.4%

Schwartz Aharon

Director

—

310,500

0.3854%

$562.01K

+78.4%

Naos Yaron

Sr. VP & COO

—

225,817

0.2803%

$408.73K

+12.4%

Forster Eliot

Director

—

7,500

0.0093%

$13.58K

—

Melincoff Gwen A

Director

—

7,500

0.0093%

$13.58K

—

Boudes Pol F

Director

—

7,500

0.0093%

$13.58K

—

Elze Christian

Director

—

7,500

0.0093%

$13.58K

—

Ben Zvi Shmuel

Director

—

7,500

0.0093%

$13.58K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bashan Dror

19 Dec 2025

PRESIDENT AND CEO

Buy

56,000

$1.81

$101.36K

Bar-Shalev Amos

18 Nov 2025

Director

Sell

168

$1.87

$314.16

What was left out

Form 4 filings counted 11

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 0

History held since 16 Sep 2016